PRAXIS PRECISION MEDICINES, INC. Convertible Preferred Stock, Shares Issued upon Conversion
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Convertible Preferred Stock, Shares Issued upon Conversion of 25.07 million shares as of 2020-10-20, per its 10-K filed 2022-02-28.
Discontinued › Notes › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2022-02-28
- 2020-10-20: Convertible Preferred Stock, Shares Issued upon Conversion 25.07M shares.
- 2020-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 25.07M shares.
- 2019-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 16.57M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2020-10-20 | 25.07M shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 25.07M shares 10-Q · filed 2020-11-23 |
| 2019-12-31 | 16.57M shares 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |